Document is current
Any future updates will be listed below
-
Authors
Zhang, Li-Ping
Wei, Yu-Min
Luo, Ming-Jie
Ren, Shu-Yue https://orcid.org/0000-0003-3259-5806
Zhan, Xiang-Wen
Wang, Chao
Li, Ze-Feng
Zhu, Rui-Min
Yan, Shuo
Cheng, Yu
Xu, Jia-Li
Yang, Xing-Jiu
Du, Ke-Lei
Wang, Jin-Qing
Zhang, Guan-nan
Du, De-Xiao
Gao, Ran
Zhao, Dong-Bing
Gong, Jia-Nan https://orcid.org/0000-0003-4977-9775
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China
- License Information
-
More Information
Article History
Received: 11 September 2024
Revised: 8 February 2025
Accepted: 25 February 2025
First Online: 12 March 2025
Competing interests
: J.N.G. is a former employee of the Walter and Eliza Hall Institute of Medical Research, who receives milestones and royalty payments related to venetoclax. All the other authors declare no conflicts of interest.
: All methods were performed in accordance with the relevant guidelines and regulations. Fresh tumor tissues were collected from GC patients during surgery after written informed consent was obtained. The study was performed with the approval of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (17-156/1412) and the Institute of Laboratory Animal Sciences (GJN22002), Chinese Academy of Medical Sciences and Peking Union Medical College. Animal study was approved by the Institutional Animal Care and Use Committee of the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, and Peking Union Medical College (IACUC 21001).
